Evidence map›Paper›PMID 32914138›Full record

ArticleF&S science2020

Short-acting testosterone appears to have lesser effect on male reproductive potential compared to long-acting testosterone in mice.

Kevin Y Chu, Shathiyah Kulandavelu, Thomas A Masterson, Emad Ibrahim, Himanshu Arora, Ranjith Ramasamy

Open access · goldAbstract read
In one paragraph

Article in F&S science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Short-Acting Testosterone: More Physiologic?Frontiers in endocrinology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kevin Y ChuDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL 33136.
Shathiyah KulandaveluDepartment of Pediatrics, University of Miami Miller School of Medicine; Interdisciplinary Stem Cell Institute, Miami, FL 33136.
Thomas A MastersonDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL 33136.
Emad IbrahimDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL 33136.
Himanshu AroraDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL 33136.
Ranjith RamasamyDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL 33136.
University of Miami · USStem Cell Institute · PA

Funding

Miami Clinical and Translational Science InstituteUL1TR002736 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN, KOBETZ, ERIN N · 2018 to 2022
$23.2M
NCATS NIH HHS UL1 TR002736
6 · The paper itself

Abstract

objectiveTo compare the effect of exogenous short-acting and long-acting testosterone on male reproductive potential in mice.

design

settingUniversity-based basic science research laboratory. ANIMALS: A total of 30 wild-type C57BL/6 male and female mice were used for this experimentation. The male mice were used for control group and testosterone supplementation, while both male and female mice were used for the breeding portion of the study.

interventionsExogenous testosterone was administered either in short-acting formulation (Monday-Wednesday-Friday dosing schedule, testosterone propionate 0.2 mg/kg), or long-acting formulation (3-month dosing schedule - testosterone pellets 150 mg) to male mice.

main outcome measuresTime to pregnancy, Luteinizing hormone (LH) levels, and testicular weight.

resultsMice treated with long-acting testosterone appear to have longer time to pregnancy when compared to wild-type (33 ± 11 vs 23 ± 2.6 days, p ≤ 0.05) and mice that received short-acting testosterone propionate (26 ± 5.9 days). Mice treated with long-acting testosterone had smaller testes weight when compared to control (0.08 ± 0.01 vs 0.11 ± 0.01g; p ≤ 0.01), while the short-acting testosterone treated mice had similar testis weight when compared to control (0.09 ± 0.02 vs 0.11 ± 0.01g; ns). The serum testosterone level was elevated in mice that received testosterone pellets (285.78 ng/dL) and testosterone propionate (122.16 ng/dL) versus control (68.4 ng/dL). In mice that received long-acting testosterone pellets, LH levels at 3 months were almost undetectable while those that received short-acting testosterone remained similar to control (0.017 ± 0.058 vs 0.348 ± 0.232 IU/L; p ≤ 0.01). Female reproductive potential parameters including litter size and pup weight were collected and observed to have no difference between groups.

conclusionThrough a mouse breeding study, mice that received short-acting testosterone were shown to have fertility potential similar to wild-type male mice. Long-acting exogenous testosterone appeared to impair male reproductive capacity and LH levels when compared to short-acting testosterone. Short-acting testosterone appeared to cause less LH suppression. Identifying strategies to increase testosterone while simultaneously preserving male fertility is important for treating young men with hypogonadism.

Indexed as

HypogonadismTestosterone PropionateAnimalsFemaleFollicle Stimulating HormoneHumansLuteinizing HormoneMaleMiceMice, Inbred C57BLPregnancyTestosteroneFollicle Stimulating HormoneLuteinizing HormoneTestosteroneTestosterone Propionatemale infertilitymouse modelreproductive potentialtestosterone

Identifiers

PMID32914138
PMCPMC7480784
OpenAlexW3016905804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.